| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |